Fig. 2From: Patient-reported outcome (PRO)-based symptom assessment in patients with advanced lung cancer receiving first-line combination immunotherapy: a protocol for a multicenter, prospective, observational studyStudy schedule of enrolment, data collection and timelineBack to article page